111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai and currently employs 1,238 full-time employees. The company went IPO on 2018-09-12. The firm mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The firm also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The firm mainly conducts its business in the domestic market.
Mr. Junling Liu est le Co-Chairman of the Board de 111 Inc, il a rejoint l'entreprise depuis 2015.
Quelle est la performance du prix de l'action YI ?
Le prix actuel de YI est de $6.55, il a diminué de 2.23% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de 111 Inc ?
111 Inc appartient à l'industrie Retail et le secteur est Consumer Staples
Quel est la capitalisation boursière de 111 Inc ?
La capitalisation boursière actuelle de 111 Inc est de $56.1M
Est-ce que 111 Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 2 analystes ont établi des notations d'analystes pour 111 Inc, y compris 4 achat fort, 4 achat, 1 maintien, 0 vente et 4 vente forte